Is Phio Pharmaceuticals Corp (PHIO) a Good Buy in the Biotechnology Industry?

Phio Pharmaceuticals Corp (PHIO) is near the middle in its industry group according to InvestorsObserver. PHIO gets an overall rating of 50. That means it scores higher than 50 percent of stocks. Phio Pharmaceuticals Corp gets a 46 rank in the Biotechnology industry. Biotechnology is number 21 out of 148 industries.

PHIO has an Overall Score of 50. Find out what this means to you and get the rest of the rankings on PHIO!

See Full PHIO Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Phio Pharmaceuticals Corp Stock Today?

Phio Pharmaceuticals Corp (PHIO) stock is higher by 6.45% while the S&P 500 is down -0.68% as of 10:11 AM on Wednesday, May 24. PHIO has risen $0.28 from the previous closing price of $4.34 on volume of 955,922 shares. Over the past year the S&P 500 is up 4.47% while PHIO is down -42.39%. PHIO lost -$10.92 per share the over the last 12 months. Click Here to get the full Stock Report for Phio Pharmaceuticals Corp stock.